ArriVent BioPharma, Inc. (AVBP)
Healthcare
Biotechnology
29.80 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
ArriVent BioPharma, Inc. (AVBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -42 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.6 | -15 | -15 | -19 | -19 | -16 | -16 | -68 | -26 | -36 | -31 | -42 | -134 | |
| – | – | – | – | – | – | – | – | – | – | -3.0 | -0.6 | – | |
| 0.2 | 0.2 | 0.3 | 0.6 | 0.8 | 0.9 | 1.0 | 2.3 | 3.3 | 3.7 | 3.2 | 5.5 | 16 | |
| 13 | -1.3 | 6.0 | -1.8 | 2.0 | 3.4 | 3.5 | -5.9 | 2.0 | -4.5 | 4.7 | -3.5 | -1.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -25 | – | 25 | – | – | – | -192 | 37 | 14 | -51 | -71 | 3.6 | -104 | |
| 0.0 | -1.0 | -1.1 | 186 | 0.4 | 0.5 | 0.1 | 6.8 | 75 | 86 | 35 | 55 | 251 | |
| 158 | -16 | 9.0 | 167 | -19 | -16 | -209 | -24 | 63 | -0.1 | -67 | 17 | 12 | |
| -8.6 | -15 | -15 | -19 | -19 | -16 | -16 | -68 | -26 | -36 | -31 | -42 | -134 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.